Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment Outcomes of Immune-Related Cutaneous Adverse Events.
Phillips GS, Wu J, Hellmann MD, Postow MA, Rizvi NA, Freites-Martinez A, Chan D, Dusza S, Motzer RJ, Rosenberg JE, Callahan MK, Chapman PB, Geskin L, Lopez AT, Reed VA, Fabbrocini G, Annunziata MC, Kukoyi O, Pabani A, Yang CH, Chung WH, Markova A, Lacouture ME. Phillips GS, et al. Among authors: markova a. J Clin Oncol. 2019 Oct 20;37(30):2746-2758. doi: 10.1200/JCO.18.02141. Epub 2019 Jun 19. J Clin Oncol. 2019. PMID: 31216228 Free PMC article.
Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients.
Phillips GS, Freites-Martinez A, Hsu M, Skripnik Lucas A, Barrios DM, Ciccolini K, Marchetti MA, Deng L, Myskowski PL, Lee EH, Markova A, Lacouture ME. Phillips GS, et al. Among authors: markova a. J Am Acad Dermatol. 2018 Jun;78(6):1102-1109. doi: 10.1016/j.jaad.2017.12.031. Epub 2017 Dec 19. J Am Acad Dermatol. 2018. PMID: 29273489 Free PMC article.
Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study.
Barrios DM, Phillips GS, Freites-Martinez A, Hsu M, Ciccolini K, Skripnik Lucas A, Marchetti MA, Rossi AM, Lee EH, Deng L, Markova A, Myskowski PL, Lacouture ME. Barrios DM, et al. Among authors: markova a. J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1340-1347. doi: 10.1111/jdv.16159. Epub 2020 Feb 5. J Eur Acad Dermatol Venereol. 2020. PMID: 31856311 Free PMC article.
Treatment of severe cutaneous adverse reaction with tocilizumab.
Hibler BP, Markova A. Hibler BP, et al. Among authors: markova a. Br J Dermatol. 2020 Oct;183(4):785-787. doi: 10.1111/bjd.19129. Epub 2020 May 10. Br J Dermatol. 2020. PMID: 32291751 Free PMC article. No abstract available.
191 results